Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Aug 10, 2026

Zimmer Biomet Q2 Earnings Call Highlights

Zimmer Biomet NYSE: ZBH reported second-quarter 2026 net sales of $2.177 billion, up 4.8% on a reported basis and 4.0% on an organic constant-currency basis, as growth in hips, specialty businesses and technology helped offset weaker performance in certain other product lines.

MarketBeat • Aug 9, 2026

Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Aug 6, 2026

Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript

Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 5, 2026

Zimmer Biomet Announces Second Quarter 2026 Financial Results

Second quarter net sales of $2.177 billion increased 4.8% on a reported basis, 4.7% on a constant currency1 basis and 4.0% on an organic constant currency1 basis Second quarter diluted earnings per share were $1.03, an increase of 33.8%; adjusted1 diluted earnings per share were $2.07, consistent with the prior year period Company updates full-year 2026 financial guidance WARSAW, Ind., Aug. 5, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH) and (SIX: ZBH) today reported financial results for the quarter ended June 30, 2026.

PRNewsWire • Aug 5, 2026

Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates

Zimmer Biomet (ZBH) came out with quarterly earnings of $2.07 per share, beating the Zacks Consensus Estimate of $2.01 per share. This compares to earnings of $2.07 per share a year ago.

Zacks Investment Research • Aug 5, 2026

ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market

ZBH beats second-quarter earnings and revenue estimates, raises its 2026 outlook and gains in pre-market despite pressure on adjusted margins.

Zacks Investment Research • Aug 5, 2026

Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Aug 5, 2026

Can These 3 MedTech Stocks Hit Targets This Earnings Season?

Can Zimmer Biomet, Charles River Laboratories and Bio-Techne meet earnings expectations? See the MedTech trends and company-specific drivers in focus.

Zacks Investment Research • Aug 4, 2026

Zimmer Biomet Set to Report Q2 Earnings: What's in the Cards?

ZBH heads into Q2 earnings with expectations of modest revenue growth as investors watch demand trends across knees, hips and robotics.

Zacks Investment Research • Jul 29, 2026